| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | D S Latchman | |
| P2860 | cites work | Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors | Q45881242 |
| Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. | Q45885582 | ||
| A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons | Q46135759 | ||
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| Heat shock proteins: protective effect and potential therapeutic use (review). | Q48326698 | ||
| Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease | Q64383353 | ||
| Human gene therapy | Q95799789 | ||
| Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence | Q34779144 | ||
| Current status review: molecular biology of herpes simplex virus latency | Q37873737 | ||
| Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor | Q38336118 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. | Q40954651 | ||
| Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector | Q40973614 | ||
| Gene transfer to neurons using herpes simplex virus-based vectors | Q41132657 | ||
| Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease | Q41169846 | ||
| Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. | Q41186665 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts | Q45877347 | ||
| Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors | Q45879552 | ||
| P433 | issue | 11 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 566-570 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Journal of the Royal Society of Medicine | Q6296198 |
| P1476 | title | Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system | |
| P478 | volume | 92 |
| Q34108056 | Gene therapy for brain tumors | cites work | P2860 |
Search more.